Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:50:22 EDT Fri 15 May 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:DMAC - DIAMEDICA THERAPEUTICS INC - https://www.diamedica.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DMAC - Q0.13.66·6.540.16.06-0.30-4.7123.26541,8556.23  6.24  6.0010.4195  3.47516:10:05May 1215 min RT 2¢

Recent Trades - Last 10 of 1855
Time ETExPriceChangeVolume
16:10:05Q6.06-0.301
16:10:05Q6.06-0.301
16:04:47Q6.06-0.301
16:01:49Q6.06-0.30459
16:01:39Q6.06-0.30717
16:00:20Q6.06-0.30290
16:00:18Q6.06-0.30243
16:00:01Q6.03-0.33100
16:00:01Q6.03-0.33157
16:00:01Q6.06-0.30602

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-05-12 16:15U:DMACNews ReleaseDiaMedica Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
2026-05-06 17:27U:DMACSEDAR Interim MD & ASEDAR Interim MD & A
2026-05-06 17:26U:DMACSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-05-06 16:30U:DMACNews ReleaseDiaMedica Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
2026-04-30 08:25U:DMACNews ReleaseDiaMedica Therapeutics to Report First Quarter 2026 Financial Results and Provide a Business Update May 7, 2026
2026-04-16 19:51U:DMACSEDAR Annual ReportSEDAR Annual Report
2026-03-30 16:45U:DMACNews ReleaseDiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights
2026-03-30 06:36U:DMACSEDAR Audited Annual Financial StatementsSEDAR MD & A
2026-03-23 08:25U:DMACNews ReleaseDiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026
2026-03-05 07:35U:DMACNews ReleaseDiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia
2026-02-24 09:23U:DMACNews ReleaseDiaMedica Therapeutics to Participate in Upcoming March Investor Conferences
2026-01-16 17:00U:DMACNews ReleaseDiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-12-18 08:45U:DMACNews ReleaseDiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
2025-11-12 17:00U:DMACSEDAR Interim Financial StatementsSEDAR Interim MD & A
2025-11-12 16:30U:DMACNews ReleaseDiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
2025-11-10 08:15U:DMACNews ReleaseDiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
2025-11-06 16:15U:DMACNews ReleaseDiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025
2025-09-29 16:15U:DMACNews ReleaseDiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
2025-09-05 08:30U:DMACNews ReleaseDiaMedica Therapeutics to Participate in Upcoming Investor Conferences
2025-09-04 10:38U:DMACSEDAR Final ProspectusSEDAR Prospectus Supplement